Form 4: Bicycle Therapeutics Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Michael Charles Ferguson Hannay, Chief Product & Supply Chain Officer of Bicycle Therapeutics PLC, sold 246 ordinary shares to cover tax withholding obligations related to the vesting of Restricted Stock Units (RSUs).
Summary
- On July 3, 2024, Michael Charles Ferguson Hannay, the Chief Product & Supply Chain Officer of Bicycle Therapeutics PLC, sold 246 ordinary shares of the company.
- The sale was executed to cover statutory tax withholding obligations associated with the vesting and settlement of RSUs.
- The shares were sold at a weighted average price of $19.64, with individual transactions ranging from $19.63 to $19.69.
- Following the transaction, Hannay directly owns 22,645 ordinary shares of Bicycle Therapeutics PLC.
Sentiment
Score: 6
Explanation: Neutral sentiment as the transaction is a routine sale to cover tax obligations and doesn't indicate a change in the executive's outlook on the company.
Industry Context
This is a routine transaction related to executive compensation and tax obligations, common in publicly traded companies. It doesn't necessarily reflect a change in the executive's confidence in the company.
Stakeholder Impact
- The sale of a small number of shares is unlikely to have a significant impact on shareholders.
Key Dates
| Date | Description |
|---|---|
| 07/03/2024 | Date of the share sale transaction. |
| 07/08/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.